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The brain is the conductor: diet-
induced inflammation overlapping 
physiological control of body 
mass and metabolism
O cérebro é o maestro: inflamação induzida por dieta interfere no 
controle fisiológico da adiposidade corporal e do metabolismo
Licio Augusto Velloso1
ABSTRACT
Obesity is currently a worldwide pandemic. It affects more than 300 million humans and it will 
probably increase over the next 20 years. The consumption of calorie-rich foods is responsible 
for most of the obesity cases, but not all humans exposed to high-calorie diets develop the dise-
ase. This fact has prompted researchers to investigate the mechanisms linking the consumption 
of high-calorie diets to the generation of an imbalance between energy intake and expenditure. 
According to recent studies, the exposure to fat-rich diets induces an inflammatory response 
in the hypothalamic areas involved in the control of feeding and thermogenesis. The inflam-
matory process damages the neuronal circuitries that maintain the homeostatic control of the 
body’s energy stores, therefore favoring body mass gain. This review will focus on the main 
advances obtained in this field. Arq Bras Endocrinol Metab. 2009;53(2):151-158.
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RESUMO
Obesidade é hoje um grave problema de saúde pública no mundo. Mais de 300 milhões de 
pessoas são obesas e esse número deve crescer substancialmente nos próximos 20 anos. As 
dietas ricas em calorias são a principal causa de obesidade, porém, nem todos os indivíduos 
expostos a dietas altamente calóricas se tornam obesos. Tal fato estimulou pesquisadores a 
investigarem os mecanismos que ligam o consumo de dietas ricas em calorias ao desenvolvi-
mento de um balanço inadequado entre consumo e gasto energético. De acordo com estudos 
recentes, o consumo de dietas ricas em gorduras induz a ativação de uma resposta inflamatória 
nas áreas do hipotálamo envolvidas com o controle da fome e da termogênese. Tal processo 
inflamatório lesa os circuitos neuronais que mantêm o controle homeostático das reservas 
corporais de energia, favorecendo assim o ganho de massa adiposa. Esta revisão irá focar os 
principais avanços obtidos nesta área. Arq Bras Endocrinol Metab. 2009;53(2):151-158. 
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INTRODUCTION
Obesity has become one of the most important health problems in the world. It affects more than 
300 million people and impinges more than 20% of peo-
ple living in selected regions, such as the United States, 
Russia, Australia, England and the Czech Republic. In 
Brazil, the current prevalence of obesity is about 10% 
and, as projected by the World Health Organization 
(WHO), it may reach 25% of the population by the year 
2025 (1). 
Except for some rare types of monogenic defects 
(2), obesity occurs due to the complex combination 
of multiple environmental and genetic factors (3). The 
consumption of highly energetic and palatable foods is 
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among the most important epidemiological predispos-
ing factors to this disease (3). However, not all people 
exposed to this type of diet develop obesity, and this 
fact has long intrigued researchers. As currently known, 
the main reason for the protective phenotype is the in-
trinsic capacity to maintain the homeostatic control of 
energy stores in the body (3). Specialized neurons of 
the hypothalamus play a central role, connecting the 
information provided by leptin and insulin, regard-
ing the size of fat depots, with the mechanisms that 
regulate hunger and thermogenesis (4). As long as the 
system is perfectly coupled, changes in energy intake 
are matched by proportional modifications in energy 
expenditure. Thus, it is clear that, in order to under-
stand the mechanisms behind the majority of obesity 
cases, the phenomena that connect the consumption of 
highly energetic foods with the loss of energy homeo-
stasis must be deciphered. 
A series of recent studies has provided a solid basis 
to the hypothesis that in diet-induced obesity, the hy-
pothalamus is targeted by an inflammatory process that 
leads to a defective regulation of energy homeostasis 
(5-8). In the present review, to discuss this complex 
mechanism, we will be presenting the physiological role 
of the hypothalamus in the control of food intake and 
energy expenditure. Next, a discussion on how nutri-
ents can disrupt the correct functioning of this highly 
specialized organ will be brought up. Finally, it the 
mechanisms involved in diet-induced hypothalamic re-
sistance to adipostatic signals will be presented.
THE PHYSIOLOGICAL CONTROL OF FOOD INTAKE 
AND THERMOGENESIS
Two distinct neuron subpopulations of the arcuate 
nucleus of the hypothalamus act as the sensors for the 
energy stores in the body and coordinate a complex net-
work of neurons that, in due course, control the balance 
of hunger versus satiety, and pro- versus anti-thermogen-
esis (9,10). These first-order neurons are equipped with 
receptors and intracellular molecular systems capable of 
detecting subtle or chronic changes in the levels of hor-
mones and nutrients present in the bloodstream (10). 
The response to these changes is based on the modula-
tion of the firing rate and of neurotransmitter produc-
tion and release by specific neuron bodies (11). 
The subpopulations of neurons of the arcuate nu-
cleus are characterized by the neurotransmitters each 
one produces. One of the subpopulations expresses the 
orexygenic peptides, NPY and AgRP, while the other 
expresses the anorexygenic POMC (α-MSH) and 
CART (10,11) (Figure 1). Both subpopulations project 
to the lateral (LH) and paraventricular (PVN) nuclei of 
the hypothalamus, where they control the functions of 
second-order neurons. In the PVN, two distinct sub-
populations of neurons produce the anorexigenic and 
pro-thermogenic neurotransmitters, TRH and CRH 
(12), while in the LH, two other subpopulations pro-
duce the predominantly orexygenic neurotransmitter 
orexin and the predominantly anti-thermogenic MCH 
(12) (Figure 1). During fasting or when body energy 
stores are depleted, the expressions of NPY and AgRP 
are induced, while POMC and CART are inhibited. 
This coordinated response is dependent on the simulta-
neous sensing of decreased nutrient availability, reduced 
levels of the adipostatic hormones leptin and insulin, 
reduced levels of the gut hormones CCK, GLP-1 and 
GIP and increased levels of the gastric hormone ghre-
lin (13). Active NPY/AgRPergic neurons send inhibi-
tory projections to the PVN, reducing the expressions 
of TRH and CRH, and stimulatory projections to the 
LH, boosting the activities of the orexin and MCH ex-
pressing neurons. Conversely, following a meal or when 
body energy stores are replenished, NPY/AgRPergic 
neurons are inhibited and POMC/CARTergic neurons 
are active. In this context, nutrient availability and the 
levels of leptin and insulin are increased, as well as the 
levels of CCK, GLP-1 and GIP. In opposition, the level 
of ghrelin is reduced. The result is the inhibition of 
orexin and MCH neurons in the LH and the activation 
of the CRH and TRH neurons in the PVN (11-13). 
Figure 1. Specialized hypothalamic neurons localized in the arcuate (Arc), paraven-
tricular (PVN) and lateral (LH) nuclei control food intake and thermogenesis (A). In each 
nuclei, at least two distinct subpopulations of neurons exert specific functions (B).
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The mechanisms by which second-order neurons 
effectively control food intake and energy expenditure 
are under intense investigation. MCH neurons play an 
important role in the control of energy expenditure 
(12,14). Increased expression of this neurotransmit-
ter restrains animal motility and reduces the expression 
of the mitochondrial uncoupling protein, UCP1, in 
brown adipose tissue, together leading to a reduction 
in energy output (12,14). Conversely, the knockout of 
MCH produces a lean phenotype due to a combined 
effect on feeding and thermogenesis (15,16), while 
the knockout of the main MCH receptor, MCHR1, 
produces a lean phenotype, predominantly due to in-
creased energy expenditure (17). Orexin has a predom-
inant role in arousal and the control of feeding (18,19). 
Injection of this neurotransmitter in the hypothalamus 
generates a potent orexigenic stimulus; however, little 
is known about the mechanisms behind this response 
(19). In opposition to the neurotransmitters of the 
LH, the PVN neurotransmitters, TRH and CRH, have 
rather overlapping roles in the control of hunger and 
thermogenesis (20,21). TRH biosynthesis and release 
is controlled by multiple inputs coming from POMC 
neurons, leptin direct signals, and from other sources 
such as T3 (22). Although most studies explore the 
role of TRH upon the control of thyroid function and, 
consequently, on thermogenesis, there are plenty of 
data showing its direct action in the control of feeding 
(23). Similarly to TRH, CRH production is modulated 
by a number of different inputs, such as signals ema-
nating from the arcuate nucleus and direct actions of 
leptin, GLP-1 and histamine (24,25). The reduction 
of appetite is the most studied effect of CRH, but sev-
eral studies point to its pro-thermogenic effects as well 
(26). Nevertheless, little is known about the mecha-
nisms controlling these phenomena. Some additional 
pathways of the central nervous system play modulato-
ry roles in energy balance. The connections of first- and 
second-order neurons of the hypothalamus with these 
systems are only beginning to be deciphered (11). The 
actions of serotonin and norepinephrine to induce sati-
ety and increase energy expenditure have been known 
for a long time (27,28). Even so, these neurotransmit-
ters play rather unspecific and minor regulatory roles 
in this context, as evidenced by the moderate/severe 
adverse effects produced by drugs acting through the 
control of these neurotransmitters and by the limited 
efficiency of all treatment regimens employing such 
drugs (29).
Recently, a new player came onto the scene. The 
development of drugs that interact with the receptor 
for the endogenous cannabinoid system revealed an ad-
ditional mechanism for the control of food intake and 
thermogenesis. The first clues about the orexygenic 
properties of endogenous cannabinoid system came 
from the observation that the consumption of exog-
enous cannabinoids present in marijuana produces a 
powerful sensation of hunger (30). The characteriza-
tion of the main endocannabinoid receptor, CB1, and 
the development of synthetic antagonists for this recep-
tor created hope for the production of new, safer and 
more effective drugs for the treatment of obesity (30). 
However, clinical data show that the weight loss pro-
duced by this class of drug is only marginally superior 
to that produced by inhibitors of serotonine re-uptake 
and adverse affects, such as depression and increased 
rate of suicide, have precluded the widespread use of 
these compounds for the treatment of obesity (31).
Although, as discussed above, a number of mecha-
nisms play a role in the control of hypothalamic neurons 
involved in the regulation of energy homeostasis, leptin 
and insulin are regarded as the most robust peripheral 
signal providers to the hypothalamus (10). Leptin is 
produced predominantly by the adipose tissue in direct 
proportion to body fat mass (32), and though some pe-
ripheral actions have been attributed to this hormone, 
such as the regulation of insulin production by pan-
creatic β-cells (33), modulation of insulin action (34), 
and control of a number of immune functions (35,36), 
the basomedial hypothalamus, particularly the arcuate 
nucleus, is the main site of its action (10,32).
Both NPY/AgRPergic and POMC/CARTergic 
neurons express high levels of the main form of the lep-
tin receptor, the ObRb (10, 32) (Figure 2). This is a 
monomeric transmembrane protein that belongs to the 
type I cytokine receptor family (32,37). Like the other 
members of this family, the ObRb lacks intrinsic enzy-
matic activity and depends on at least one associated 
kinase, JAK2, to transduce its signal (37). Upon lep-
tin binding to the ObRb, a dimmerization of receptor 
units accompanies JAK2 autophosphorylation and the 
tyrosine phosphorylation of two residues (Tyr985 and 
Tyr1138) in the receptor itself (37). These events gen-
erate the possibility of activation of at least three distinct 
intracellular signaling pathways (37). Tyrosine phos-
phorylation of Tyr985 recruits the tyrosine phosphatase 
SHP2, which mediates the activation of the p21ras/
ERK signaling pathway (32,37). Tyrosine phosphory-
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lation of Tyr1138 recruits STAT3 to the ObRb, leading 
to STAT3 tyrosine phosphorylation and translocation 
to the nucleus, providing a fast-track for leptin-induced 
control of gene expression (32). Finally, the autophos-
phorylation of JAK2 leads to the recruitment and ty-
rosine phosphorylation of adaptor proteins IRS1/2, 
which promotes the activation of PI3-kinase and its 
downstream signaling (32). It is possible that several 
other signaling pathways are also activated through the 
ObRb. These may include other substrates for JAK2, 
since a large number of Tyr residues may be phospho-
rylated following kinase activation, and the engagement 
of as yet unknown tyrosine kinases, since signal trans-
duction through IRS1/PI3-kinase/Akt can occur even 
in the absence of the activation of JAK2 (35). 
Each of the signaling pathways controlled by leptin 
plays a role in a specific compartment of the complex 
response to this hormone. In POMC/CARTergic neu-
rons, the activation of JAK2/STAT3 signaling by leptin 
leads to increased transcriptional activity, boosting the 
expression of POMC (10,12). This effect is enhanced 
by simultaneous insulin action, but apparently not re-
produced by insulin alone (38). Conversely, the activa-
tion of PI3 kinase activity seems to play a minor role 
in the control of neurotransmitter expression, but it 
is essential for neurotransmitter release in the synaptic 
terminals. This effect is achieved through the control of 
neuronal firing rate. Once activated by either leptin or 
insulin, PI3 kinase mediates neuronal depolarization by 
inhibiting ATP-sensitive potassium channels (11,39). 
The central role for PI3 kinase in this context is further 
evidenced by the fact that genetic or pharmacological 
modulations of phosphatases that control the signal-
ing through PI3 kinase, such as PTEN and 5’-ptase IV, 
have profound effects on feeding behavior (40,41). 
Since not only POMC/CARTergic neurons, but 
also the orexigenic NPY/AgRPergic neurons harbor 
the leptin receptor, an important question was raised re-
garding the mechanisms by which leptin can simultane-
ously activate the anorexygenic neurons, while inhibit-
ing the orexigenic neurons. The answer to this question 
came from the demonstration that POMC/CARTergic 
neurons project inhibitory fibers to NPY/AgRPergic 
neurons. When leptin levels are high, the activation of 
POMC/CARTergic neurons leads to a simultaneous 
inhibition of NPY/AgRPergic neurons, a phenomenon 
that superimposes the direct signals that are eventually 
generated through the ObRb, as well as the insulin re-
ceptor present in these orexigenic neurons (11).
Finally, it is important to mention that, besides its 
predominant actions in the arcuate nucleus, a number 
of studies have shown that leptin can act through cells 
present in other regions of the brain. Some of these cells 
may act only to modulate the main signals delivered 
by arcuate nucleus neurons, but in some cases, specific 
responses may control other physiological phenomena 
primarily controlled by leptin (42).
Insulin is the second most important adipostatic 
signal provider to the hypothalamus. Studies from 
the late 1960’s pioneered the investigation concern-
ing the roles of insulin in the central nervous system 
(43). However, only after the identification of leptin in 
1994 were the functions of insulin in the hypothalamus 
described (38,44). In the arcuate nucleus, both NPY/
AgRPergic and POMC/CARTergic neurons express 
receptors for insulin (4,10). As in peripheral tissues, in 
the hypothalamus, insulin activates signal transduction 
through IRS1 and IRS2, leading to the engagement 
of the PI3K/Akt/Foxo1 pathway (10,38,45). In ad-
dition, insulin induces a potent cross-talk with the lep-
tin signaling pathway through the activation of JAK2 
(38). In fact, one of the most important functions of 
insulin in the hypothalamus is to enhance leptin’s signal 
(10,38). In the absence of the insulin signal in the hy-
Figure 2. Leptin and insulin are the main adipostatic hormones signaling to the 
hypothalamus. The main signal transducing pathways and inhibitor mechanisms 
induced by diet and other inflammatory factors are depicted. 
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pothalamus, much of the adipostatic function of leptin 
is lost, as demonstrated using neuron-specific insulin 
receptor knockout mice (46). 
Therefore, under physiological conditions the hy-
pothalamus, acting under the control of peripheral fac-
tors, coordinates perfect coupling between food intake 
and energy expenditure. As long as the system is fully 
active, body mass is maintained steady. 
INDUCTION HYPOTHALAMIC DYSFUNCTION BY 
NUTRIENTS
Excessive caloric intake, despite the type of nutrient 
consumed, is a primary risk factor for the development 
of obesity (47). However, a number of epidemiological 
studies have shown that populations consuming pref-
erentially diets rich in fat are especially prone to gain 
body mass (48,49). In addition to its caloric value, 
fatty acids are known to exert functional modulation of 
several tissues and cell types. Therefore, we tested the 
hypothesis that high fat consumption could modulate 
gene expression in the hypothalamus. Using a macroar-
ray approach, the expressions of more than 1,000 hy-
pothlamic genes were simultaneously evaluated. More 
than 15% of the analyzed genes were somehow modu-
lated by the diet. Clustering the genes by function re-
vealed that immune response related to genes were the 
most affected (5,50). Among the fatty acids commonly 
present in the occidental diet, the long-chain saturated 
ones are the most harmful. By activating signal trans-
duction through receptors of the toll-like receptor 
family, especially the TLR4, these fatty acids activate 
an inflammatory response by the microglia cells in the 
hypothalamus (6). Signaling through JNK and NFκB 
leads to the induction of cytokine gene transcription 
and local levels of TNF-α, IL-1β, IL-6 and IFN-γ raise 
and nourish hypothalamic inflammation (6). 
Following fatty acid-induced activation of TLR4 sig-
naling, cells turn on an adaptive mechanism that has the 
biological purpose of adapting protein synthesis to the 
harms imposed by the inflammation. This mechanism is 
called endoplasmic reticulum stress and, depending on 
the magnitude and duration of the harm, can enhance 
inflammatory signal or induce apoptosis (51).
The ER is the organelle responsible for the synthe-
sis and processing of membrane and secretory proteins 
(52). When the ER homeostasis is disrupted, the ac-
cumulation of misfolded and unfolded proteins in the 
ER lumen ensues (52,53). To deal with this condition, 
the affected cells activate a complex signaling system 
known as the unfolded protein response (UPR), aimed 
at preserving cell integrity, while the harmful condition 
persists (52,53). One of the outcomes of the activation 
of UPR is the induction of the expression of cytokines 
and proteins involved in immune surveillance (54,55). 
If the exposure to saturated fatty acids is prolonged 
and, depending on some as yet unknown genetic deter-
minants, a pro-apototic response is induced, leading to 
the preferential loss of anorexigenic neurons in the arc-
uate nucleus (Moraes and Velloso, unpublished results). 
As time passes, a gradual modification in the relative 
numbers of orexygenic and anorexygenic neurons takes 
place and a novel set point for body adiposity is gener-
ated. This fact may explain why some obese patients are 
so resistant to different behavioral and pharmacological 
approaches employed to treat obesity. Thus, activation 
of TLR4 signal transduction, followed by the induc-
tion of hypothalamic ER-stress, is the main mechanisms 
linking the high consumption of dietary fats to the in-
duction of hypothalamic dysfunction in obesity.
MECHANISMS INVOLVED IN DIET-INDUCED 
HYPOTHALAMIC RESISTANCE TO ADIPOSTATIC 
SIGNALS
As long as a perfect coupling between caloric intake and 
energy expenditure is preserved, body adiposity is main-
tained at a physiological level (47). One of the mecha-
nisms involved in the breakdown of this equilibrium is 
the installation of resistance to the anorexigenic and ther-
mogenic effects of leptin and insulin (5). In animal mod-
els, the resistance to both hormones can be quantified by 
a simple method. In intracerebroventricular cannulated 
lean rodents, the acute injection of leptin leads to a re-
duction of up to 60% of spontaneous food intake over 12 
hours (38). Injecting insulin rather then leptin produces 
a reduction of up to 50% in food intake. However, if the 
same tests are performed in obese animals, the effects of 
both hormones are blunted by at least 50%. To identify 
the molecular mechanism responsible for producing the 
functional resistance to leptin and insulin, several groups 
have evaluated different models of obesity and the most 
remarkable findings reveal that, upon diet-induced obe-
sity, the induction of inflammatory activity, specifically in 
the hypothalamus, leads to the activation of intracellular 
signaling pathways that promote a negative cross-talk 
with the leptin and insulin signaling systems, which im-
pairs their physiological anorexygenic activities (38,45).
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Currently, four distinct mechanisms are known to 
play a role in diet- and cytokine-induced resistance to 
leptin and/or insulin in the hypothalamus of rodents. 
Both TNF-α and the consumption of fat-rich diets can 
induce the activation of the serine-kinase JNK in hypo-
thalamic cells. Activated JNK targets IRS1, catalyzing 
its serine phosphorylation and hampering its capacity 
to act appropriately as a docking protein for PI3-ki-
nase. This results in reduced insulin-induced activation 
of Akt coincides with functional resistance to insulin. 
Inhibition of JNK by a specific chemical inhibitor or 
inhibition of TNF-α by a blocking monoclonal anti-
body reverses the effects of the diet or the cytokine and 
reestablishes a normal tonus for insulin activity in the 
hypothalamus (5). 
IKK, the serine kinase involved in IkB phosphoryla-
tion/degradation, which leads to NFκB activation, is 
another mediator involved in diet-induced insulin re-
sistance in the hypothalamus (7). In rats fed on a diet 
rich in fat, activated IKK promotes the serine phospho-
rylation of  IRS1, hampering the signal transduction of 
insulin. Whilst in peripheral organs of insulin resistant 
animals, the inhibition of IKK by salicylates was proven 
to reinstall correct insulin activity (56), no data regard-
ing the pharmacological inhibition of this enzyme in 
the hypothalamus is available so far, but it is expected 
to work in a similar manner.
SOCS3 belongs to a family of inducible proteins 
that respond to stimulus by a number of cytokines, 
hormones and growth factors. Once expressed, SOCS 
proteins provide a negative feedback to the original sig-
nal, acting as a regulatory loop to restrain over stimula-
tion. In diet-induced obesity, the expression of SOCS3 
is significantly stimulated in the hypothalamus, pro-
viding a negative control for leptin and insulin signal-
ing (57,58). At least two mechanisms are involved in 
SOCS3 inhibition of leptin and insulin signaling. The 
first one depends on the physical interaction of SOCS3 
with either the ObRb or STAT3 (32). Under these cir-
cumstances, the transduction of the signal is inhibited 
because the sites for interaction between proteins are 
blocked by SOCS3. The second mechanism depends 
on SOCS3-dependent ubiquitination of IRS proteins. 
Following ubiquitin tagging, IRS proteins are directed 
to proteosomic degradation, restraining signal trans-
duction through this pathway (32). The important role 
for SOCS3 in diet-induced obesity is further confirmed 
by the fact that genetic abrogation of SOCS3 is capable 
of protecting mice from diet-induced obesity (32).
An additional mechanism involved in diet- and 
cytokine-induced resistance to anorexigenic signaling 
in the hypothalamus is the induction of expression of 
the tyrosine phosphatase PTP1B. Once induced, this 
enzyme catalyses the dephosphorylation of the IR and 
IRS proteins, turning off the signals generated by in-
sulin. The knockout of the PTP1B gene or the knock-
down of PTP1B by antisense oligonucleotides protects 
experimental animals from diet- and cytokine-induced 
insulin resistance in the hypothalamus (59).
CONCLUDING REMARKS
Following the identification of leptin, 15 years ago, 
great advance has been obtained in the understanding 
of physiological mechanisms of body mass control. It 
has allowed a substantial advance in the characteriza-
tion of the mechanisms involved in the development 
of obesity. It is currently believed that, in most of the 
obesity cases, the hypothalamus is the primarily affected 
organ. Upon high consumption of dietary fat, a local 
inflammatory process is triggered by the activation of 
TLR4 signaling. Neurons and microglia are affected 
and ER-stress is induced. Depending on genetic back-
ground, specific subpopulations of neurons are lost by 
apoptosis, thus enhancing the harmful effects of inflam-
mation. With time, the homeostatic control of body 
energy stores is lost and obesity emerges. Future studies 
will focus on the characterization of similar phenomena 
in human beings and on the evaluation of specific anti-
inflammatory approaches to treat obesity.  
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